Press Release

View printer-friendly version

<< Back

AMAG Pharmaceuticals to Present at Upcoming Investor Conferences

WALTHAM, Mass., Nov. 13, 2019 (GLOBE NEWSWIRE) -- AMAG Pharmaceuticals, Inc. (NASDAQ:AMAG) today announced that company management will participate in the following investor conferences:

  • Jefferies 2019 London Healthcare Conference
    Wednesday, November 20, 2019 at 5:20 p.m. GMT (12:20 p.m. EST)
    London, U.K.

  • Piper Jaffray Healthcare Conference
    Wednesday, December 4, 2019 at 2:30 p.m. EST
    New York, NY

A live audio webcast will be accessible through the Investors section of the company’s website at www.amagpharma.com. A replay of the webcast will be archived on the company’s website for 30 days.

About AMAG
AMAG is a pharmaceutical company focused on bringing innovative products to patients with unmet medical needs. The company does this by leveraging its development and commercial expertise to invest in and grow its pharmaceutical products across a range of therapeutic areas, including women’s health. For additional company information, please visit www.amagpharma.com.

AMAG Pharmaceuticals® and the logo are registered trademarks of AMAG Pharmaceuticals, Inc. 

AMAG Pharmaceuticals Contact:
Loraine Spreen
617-866-0303

 

AMAG Pharmaceuticals logo

Source: AMAG Pharmaceuticals, Inc.